Impact of fremanezumab on headache intensity and duration of remaining migraine attacks: PEARL 3rd interim analysis

被引：0
|
作者：
Tassorelli, C. [1 ,2 ]
Mitsikostas, D. [3 ]
Amin, F. [4 ,5 ]
Kokturk, P. [6 ]
Schankin, C. [7 ]
Sahin, G. [8 ]
Pozo-Rosich, P. [9 ,10 ]
Dorman, P. [11 ]
Nezadal, T. [12 ]
Poole, A. [13 ]
Martins, I. [14 ]
Sumelahti, M. [15 ]
Krasenbaum, L. [16 ]
Ahn, A.
Akcicek, H. [6 ]
Ashina, M. [17 ,18 ]
机构：
[1] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[2] IRCCS Mondino Fdn, Pavia, Italy
[3] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, Athens, Greece
[4] Copenhagen Univ Hosp Rigshosp Glostrup, Dept Neurol, Danish Headache Ctr, Copenhagen, Denmark
[5] Univ Copenhagen, Dept Neurorehabilitat Traumat Brain Injury, Rigshosp Glostrup, Copenhagen, Denmark
[6] Teva Netherlands BV, Amsterdam, Netherlands
[7] Univ Bern, Univ Hosp Bern, Dept Neurol, Inselspital, Bern, Switzerland
[8] Lund Univ, Dept Clin Sci Lund, Skaneuro Neurol Clin, Lund, Sweden
[9] Univ Autonoma Barcelona, Headache Unit, Barcelona, Spain
[10] Univ Autonoma Barcelona, Vall dHebron Hosp & Res Inst, Res Grp, Barcelona, Spain
[11] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle, England
[12] Charles Univ Prague, Inst Neuropsychiat Care, Sch Med 1, Prague, Czech Republic
[13] Oslo Headache Ctr, Oslo, Norway
[14] Univ Lisbon, Ctr Estudos Egas Moniz, Fac Med, Lisbon, Portugal
[15] Univ Tampere, Fac Med & Hlth Technol, Tampere, Finland
[16] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[17] Copenhagen Univ Hosp Rigshosp Glostrup, Danish Headache Ctr, Dept Neurol, Copenhagen, Denmark
[18] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-583
引用
收藏
页码：690 / 690
页数：1
相关论文
共 50 条
  • [1] Fremanezumab adherence & persistence along with past & concomitant migraine medication use: PEARL 3rd interim analysis
    Tassorelli, C.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Schankin, C.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A.
    Martins, I.
    Sumelahti, M.
    Krasenbaum, L.
    Ahn, A.
    Lyras, L.
    Ashina, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 689 - 689
  • [2] Real-world effectiveness & safety of fremanezumab in migraine: 3rd interim analysis of the pan-European PEARL study
    Ashina, M.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Schankin, C.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A.
    Martins, I.
    Sumelahti, M.
    Campos, V. Ramirez
    Ning, X.
    Lyras, L.
    Tassorelli, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 149 - 150
  • [3] Real-World effectiveness and safety of fremanezumab in migraine: 3rd interim analysis of the pan-european PEARL study
    Ashina, M.
    Mitsikostas, D. D.
    Amin, F. Mohammad
    Kokturk, P.
    Schankin, C. J.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A. Christine
    Martins, I. Pavao
    Sumelahti, M. L.
    Campos, V. Ramirez
    Ning, X.
    Lyras, L.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [4] Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
    Ashina, M.
    Mitsikostas, D.
    Amin, F. M.
    Kokturk, P.
    Sahin, G.
    Schankin, C.
    Dorman, P.
    Pozo-Rosich, P.
    Lyras, L.
    Myers, C.
    Ahn, A.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [5] Real-world effectiveness of switching to fremanezumab from other CGRP pathway targeting mAbs: PEARL 3rd interim analysis
    Ashina, M.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Schankin, C.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A.
    Martins, I.
    Sumelahti, M.
    Campos, V. Ramirez
    Ning, X.
    Akcicek, H.
    Tassorelli, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 371 - 372
  • [6] Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal M.
    Kokturk, Pinar
    Sahin, Gurdal
    Schankin, Christoph J.
    Dorman, Paul J.
    Pozo-Rosich, Patricia
    Lyras, Leonidas
    Myers, Coleen
    Ahn, Andrew
    Tassorelli, Cristina
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 93 - 94
  • [7] Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal M.
    Kokturk, Pinar
    Sahin, Gurdal
    Schankin, Christoph J.
    Dorman, Paul J.
    Pozo-Rosich, Patricia
    Lyras, Leonidas
    Myers, Coleen
    Ahn, Andrew H.
    Tassorelli, Cristina
    NEUROLOGY, 2023, 100 (17)
  • [8] ATTACKS OF HEADACHE - COLLOID CYST OF 3RD VENTRICLE
    ULRICH, J
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1978, 67 (10): : 349 - 352
  • [9] Long-term effect of fremanezumab on the overall number of headache hours and on the duration of remaining headaches in patients with chronic or episodic migraine
    Lipton, R. B.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    Ning, X.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [10] The impact of chronic migraine on the quality of life and on the national health system in patients attending an Italian 3rd level headache centre
    Berra, E.
    De Icco, R.
    Avenali, M.
    Berlangieri, M.
    Allena, M.
    Sances, G.
    Cristina, S.
    Ghiotto, N.
    Guaschino, E.
    Bolla, M.
    Tassorelli, C.
    Nappi, G.
    Sandrini, G.
    CEPHALALGIA, 2015, 35 : 159 - 160
12345